<乌鸦传媒>Rapid Heart Rate Tied to Higher Mortality in Cancer Patients Unexplained tachycardia linked with threefold increase in risk of death Jan 28, 2019
<乌鸦传媒>Genetic Profiling Disappoints for CUP Survival But testing in cancer of unknown primary site did help with prognosis Jan 24, 2019
<乌鸦传媒>High Response Rate in HER2+ Esophagogastric Cancer Summary findings from the Gastrointestinal Cancers Symposium Jan 23, 2019
<乌鸦传媒>Death Risk Rises With No Colonoscopy After Stage I CRC Three-fold increase, but is colonoscopy the driver? Jan 22, 2019
<乌鸦传媒>Mixed Results with Immune Tx in Advanced, Refractory Colon Ca Overall survival gains were modest to none in different stages of CRC Jan 20, 2019
<乌鸦传媒>Metastatic Gastric Ca Treatments Show Mixed Results FTD/TPI effective, but mFOLFOX plus biologic didn't improve survival Jan 20, 2019
<乌鸦传媒>'Incredibly Impressive' Activity in Biliary Ca with Combo Tx Responses in about 40% of patients with BRAF/MEK inhibitor pairing Jan 20, 2019
<乌鸦传媒>Will Biomarkers Eventually Replace Physicians? Milton Packer imagines the end of nonprocedural medicine as we know it Jan 16, 2019
<乌鸦传媒>Surgery/HIPEC Safer Than Other High-Risk Cancer Procedures Lower infection, 30-day mortality rates than with Whipple, esophagectomy Jan 15, 2019
<乌鸦传媒>Active Smokers Far More Likely to Fail on Chemo for Bladder Ca Higher rates of disease recurrence seen as well Jan 10, 2019
<乌鸦传媒>V600K-Mutant Melanoma May Merit First-Line Immunotherapy Higher mutational load is less responsive to targeted therapy with BRAF/MEK inhibition Jan 10, 2019
<乌鸦传媒>Less Invasive Surgery Wins in Esophageal Cancer Large reduction in major complications at 1 month out Jan 09, 2019
<乌鸦传媒>Does Johnson's Baby Powder Cause Cancer? Milton Packer says the $4.69-billion verdict is about anger, not medicine Jan 09, 2019
<乌鸦传媒>Trump Proposes Overhaul of Part B Drugs Plan hinges on benchmarking U.S. prices to those abroad Jan 04, 2019
<乌鸦传媒>MSI Status in Prostate Ca Could ID Immunotherapy Responders But not all MSI-high patients saw benefit with checkpoint inhibitors Dec 27, 2018
<乌鸦传媒>Cancer Treatment and Arthritis: A Growing Complaint Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
<乌鸦传媒>Increased Risk of Chemo-Associated AML for Nearly All Solid Cancers Extended beyond 5 years for most types with greater risk seen in young patients Dec 20, 2018
<乌鸦传媒>Kidney Stones Tied to Renal Carcinoma But more research is needed to unravel mechanisms behind the relationships, study authors say Dec 20, 2018
<乌鸦传媒>Sorafenib 'New Standard of Care' for Patients With Desmoid Tumors Toxicity led to treatment discontinuation in 20% of patients Dec 19, 2018
<乌鸦传媒>Higher Risk of Shingles Seen in Patients With Certain Cancers Vaccine development may help with prevention of herpes zoster in this population Dec 14, 2018
<乌鸦传媒>Immunotherapy Combo Flops in Metastatic NSCLC Durvalumab plus tremelimumab failed to improve survival versus chemotherapy Dec 13, 2018
<乌鸦传媒>Patients Say Quality of Life Suffered With Mastectomy for Early Breast Cancer Breast-conservation options were associated with better sexual, psychosocial outcomes Dec 07, 2018
<乌鸦传媒>Visual Guide to AVERT's VTE Prevention in Cancer Apixaban effective against important chemotherapy side effect Dec 07, 2018
<乌鸦传媒>ASH Poster Rounds: Adding BTK Inhibitor Safe in First-Line MCL Plus: Lenalidomide upfront in PTCL; skipping RT in primary mediastinal B-cell lymphoma Dec 07, 2018
<乌鸦传媒>SABCS: Axillary RT as Good as Surgery in Breast Cancer Radiation non-inferior to surgery after positive sentinel node Dec 07, 2018
<乌鸦传媒>Low-Dose Tamoxifen Feasible Option in Breast Cancer Women appear to prevent recurrence in early stage cancers with 5 mg dosing Dec 06, 2018
<乌鸦传媒>ASH Poster Rounds: Obesity Impacts CLL Survival in Women Plus: New risk model predicts CLL survival; novel BTK inhibitor works after ibrutinib Dec 06, 2018
<乌鸦传媒>Xeloda Disappoints in Early Triple-Negative Breast Cancer No improvement after standard chemo, though subset may derive some benefit Dec 05, 2018
<乌鸦传媒>T-DM1: A New Adjuvant Standard in High-Risk HER2+ Breast Ca? Substantial improvements in survival outcomes in KATHERINE trial Dec 05, 2018
<乌鸦传媒>Cancer-VTE Trial Falls Short High dropout rate undermines rivaroxaban prophylaxis trial Dec 05, 2018
<乌鸦传媒>Chemo-Free Tx Tops Best Option in Younger CLL Patients Improved overall survival and safety with ibrutinib-based therapy Dec 04, 2018
<乌鸦传媒>Combination Regimen Extends PFS in Myeloma Large benefit but relevance of comparator questioned Dec 04, 2018
<乌鸦传媒>$2 Test Could Transform Sickle Cell Dx in Africa May have applications in high-income countries as well Dec 04, 2018
<乌鸦传媒>ASH Offers Early Look at Updated SCD Guidelines Experts formulated >50 recommendations on sickle cell disease Dec 03, 2018
<乌鸦传媒>Add-On Drugs Could Boost Efficacy, Tolerability of CAR T-Cell Therapies Studies test addition of targeted agents, immunotherapy Dec 03, 2018
<乌鸦传媒>SABCS: Translational Before It Was Cool Growing, evolving while adhering to founding principles Dec 03, 2018
<乌鸦传媒>CAR T-Cell Responses Prove Durable in ALL, DLBCL Two studies demonstrate long-term control in relapsed/refractory disease Dec 01, 2018
<乌鸦传媒>Cutting Chemo Cycles Feasible in Younger DLBCL Patients Patients, ages 18-60, fare well with four cycles of CHOP instead of six Dec 01, 2018
<乌鸦传媒>Ibrutinib Alone Wins in Older CLL Patients Adding rituximab offered no added benefit Dec 01, 2018
